These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Isolation of mesenchymal stromal cells from extraembryonic tissues and their characteristics. Veryasov VN; Savilova AM; Buyanovskaya OA; Chulkina MM; Pavlovich SV; Sukhikh GT Bull Exp Biol Med; 2014 May; 157(1):119-24. PubMed ID: 24909727 [TBL] [Abstract][Full Text] [Related]
25. Immunological basis of stem cell therapy in liver diseases. Cui L; Shi Y; Han Y; Fan D Expert Rev Clin Immunol; 2014 Sep; 10(9):1185-96. PubMed ID: 24964800 [TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cells for the treatment of heart disease. Yamahara K; Nagaya N Regen Med; 2007 Mar; 2(2):107-9. PubMed ID: 17465743 [No Abstract] [Full Text] [Related]
27. Macrophages regulate smooth muscle differentiation of mesenchymal stem cells via a prostaglandin F₂α-mediated paracrine mechanism. Lee MJ; Kim MY; Heo SC; Kwon YW; Kim YM; Do EK; Park JH; Lee JS; Han J; Kim JH Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2733-40. PubMed ID: 22962328 [TBL] [Abstract][Full Text] [Related]
28. Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma. Motaln H; Gruden K; Hren M; Schichor C; Primon M; Rotter A; Lah TT Cell Transplant; 2012; 21(7):1529-45. PubMed ID: 22554389 [TBL] [Abstract][Full Text] [Related]
29. Mesenchymal stem cell based therapy for osteo-diseases. Ghasroldasht MM; Irfan-Maqsood M; Matin MM; Bidkhori HR; Naderi-Meshkin H; Moradi A; Bahrami AR Cell Biol Int; 2014 Oct; 38(10):1081-5. PubMed ID: 24797260 [TBL] [Abstract][Full Text] [Related]
30. Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations. Wang J; Liao L; Wang S; Tan J Cytotherapy; 2013 Aug; 15(8):893-904. PubMed ID: 23751203 [TBL] [Abstract][Full Text] [Related]
31. Mesenchymal Stem Cells as a Source of Repair Cytokines: Mesenchymal Stem Cells as the Conductor. Stoddart MJ J Am Acad Orthop Surg; 2015 Jul; 23(7):452-3. PubMed ID: 26040952 [No Abstract] [Full Text] [Related]
32. Encapsulated mesenchymal stem cells for in vivo immunomodulation. Zanotti L; Sarukhan A; Dander E; Castor M; Cibella J; Soldani C; Trovato AE; Ploia C; Luca G; Calvitti M; Mancuso F; Arato I; Golemac M; Jonjic N; Biondi A; Calafiore R; Locati M; D'Amico G; Viola A Leukemia; 2013 Feb; 27(2):500-3. PubMed ID: 22878604 [No Abstract] [Full Text] [Related]
33. Dissecting paracrine effectors for mesenchymal stem cells. Bruno S; Collino F; Tetta C; Camussi G Adv Biochem Eng Biotechnol; 2013; 129():137-52. PubMed ID: 22968371 [TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stromal cells: are they ready for prime time? Kamani NR Transfusion; 2016 Apr; 56(4):1S. PubMed ID: 27079317 [No Abstract] [Full Text] [Related]
36. Support of hepatic regeneration by trophic factors from liver-derived mesenchymal stromal/stem cells. Fouraschen SM; Hall SR; de Jonge J; van der Laan LJ Methods Mol Biol; 2014; 1213():89-104. PubMed ID: 25173377 [TBL] [Abstract][Full Text] [Related]
38. Clinical study using adipose-derived mesenchymal-like stem cells in acute myocardial infarction and heart failure. Panfilov IA; de Jong R; Takashima S; Duckers HJ Methods Mol Biol; 2013; 1036():207-12. PubMed ID: 23807797 [TBL] [Abstract][Full Text] [Related]
39. Use of mesenchymal stem cells as treatment for graft-versus-host disease: current knowledge and controversies. Ortín M; Sierra J Immunotherapy; 2011 Jun; 3(6):701-4. PubMed ID: 21668303 [No Abstract] [Full Text] [Related]
40. Isolation, characterization, differentiation, and application of adipose-derived stem cells. Kuhbier JW; Weyand B; Radtke C; Vogt PM; Kasper C; Reimers K Adv Biochem Eng Biotechnol; 2010; 123():55-105. PubMed ID: 20091288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]